Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 947


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
Year : 2013  |  Volume : 54  |  Issue : 3  |  Page : 185-190

Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy

1 Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria
2 Department of Medicine, Aminu Kano Teaching Hospital; Department of Medicine, Bayero University, Kano, Nigeria
3 Department of Medicine, Jos University Teaching Hospital, Jos, Plateau State, Nigeria

Correspondence Address:
Mahmoud Umar Sani
Cardiology Unit, Department of Medicine, Aminu Kano Teaching Hospital, PMB 3452, Kano, Kano State
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0300-1652.114591

Rights and Permissions

Background: Highly active antiretroviral therapy (HAART) has become more accessible to Human immunodeficiency virus infection/Acquired Immunodeficiency Syndrome (HIV/AIDS) patients worldwide. There is growing concern that the metabolic complications associated with HIV and HAART may increase cardiovascular risk and lead to cardiovascular diseases. We, therefore, set out to describe the cardiovascular risk profile of HIV/AIDS patients receiving HAART at a health facility in northern part of Nigeria. Materials and Methods: This cross-sectional study was conducted at the Aminu Kano Teaching Hospital, Kano, Nigeria. Consenting patients, who had been receiving HAART, were compared with age and sex matched HAART-naive subjects. Questionnaire interview, electrocardiography, anthropometric and blood pressure measurements were conducted under standard conditions. Blood samples were obtained for the determination of plasma glucose, uric acid and lipid levels. Results: Two hundred subjects were studied, 100 were on HAART (group 1) and the other 100 (group 2) were HAART-naive. Subjects' mean age for all the participants was 32.5 (7.6) years. The prevalence of hypertension was 17% in group 1 and 2% in group 2 ( P < 0.001). Similarly, 11% and 21% of group 1 subjects were obese or had metabolic syndrome compared with 2% and 9% of group 2 patients ( P < 0.05 for both) . Conclusion: HAART treatment was associated with significantly higher prevalences of hypertension, obesity and metabolic syndrome.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded219    
    Comments [Add]    
    Cited by others 28    

Recommend this journal